CL2013001313A1 - Composicion que comprende microorganismos probióticos no replicantes para prevenir o tratar infecciones gastrointestinales - Google Patents

Composicion que comprende microorganismos probióticos no replicantes para prevenir o tratar infecciones gastrointestinales

Info

Publication number: CL2013001313A1
Authority: CL; Chile
Prior art keywords: composition; prevent; probiotic microorganisms; gastrointestinal infections; treat gastrointestinal
Prior art date: 2010-11-11

Application number

CL2013001313A

Other languages

English (en)

Inventor

Annick Mercenier

Sophie Nutten

Valerie Petit

Clara Lucia Garcia-Rodenas

Monique Julita

Guenolee Prioult

Original Assignee

Nestes S A

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-11-11

Filing date

2013-05-10

Publication date

2014-03-07

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43618887&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2013001313(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2013-05-10 Application filed by Nestes S A filed Critical Nestes S A

2014-03-07 Publication of CL2013001313A1 publication Critical patent/CL2013001313A1/es

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/116—Polyvalent bacterial antigens
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Microbiology (AREA)
Mycology (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

CL2013001313A 2010-11-11 2013-05-10 Composicion que comprende microorganismos probióticos no replicantes para prevenir o tratar infecciones gastrointestinales CL2013001313A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP10190847A EP2455094A1 (en)	2010-11-11	2010-11-11	Non-replicating probiotic micro-organisms protect children against gastrointestinal infections

Publications (1)

Publication Number	Publication Date
CL2013001313A1 true CL2013001313A1 (es)	2014-03-07

Family

ID=43618887

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CL2013001313A CL2013001313A1 (es)	2010-11-11	2013-05-10	Composicion que comprende microorganismos probióticos no replicantes para prevenir o tratar infecciones gastrointestinales

Country Status (17)

Country	Link
US (1)	US9345728B2 (es)
EP (2)	EP2455094A1 (es)
CN (1)	CN103282040A (es)
AU (1)	AU2011328137A1 (es)
BR (1)	BR112013011759A2 (es)
CA (1)	CA2817407A1 (es)
CL (1)	CL2013001313A1 (es)
ES (1)	ES2542956T3 (es)
IL (1)	IL226210A0 (es)
MX (1)	MX336125B (es)
PH (1)	PH12013500918A1 (es)
PL (1)	PL2637677T3 (es)
PT (1)	PT2637677E (es)
RU (1)	RU2568830C2 (es)
SG (1)	SG190170A1 (es)
WO (1)	WO2012062781A1 (es)
ZA (1)	ZA201304245B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY171851A (en)	2011-06-20	2019-11-04	Heinz Co Brands H J Llc	Probiotic compositions and methods
KR101166798B1 (ko) *	2011-12-19	2012-07-26	김대현	락토바실러스 애시도필러스 엘비의 사균을 포함하는 알레르기 질환의 치료 또는 예방용 의약 조성물
ES2883552T3 (es)	2012-06-18	2021-12-09	Heinz Co Brands H J Llc	Trastornos relacionados con el gluten
US9987316B2 (en)	2012-09-14	2018-06-05	Case Western Reserve University	Probiotic controlling fungi and uses thereof
PT2994150T (pt)	2013-05-10	2019-06-14	Heinz Co Brands H J Llc	Probióticos e métodos de utilização
CN110964665B (zh) *	2019-12-20	2020-09-25	哈尔滨美华生物技术股份有限公司	一种用于胃切除术后治疗的益生菌组合物及其制备方法
CN118308273B (zh) *	2024-06-07	2024-08-09	山东中科嘉亿生物工程有限公司	一种能够抵抗抗生素、改善便秘的益生菌剂及其应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69219768T2 (de)	1992-07-06	1997-08-28	Societe Des Produits Nestle S.A., Vevey	Milchbakterien
IT1284877B1 (it) *	1996-08-09	1998-05-22	Dicofarm Spa	Trattamento delle diarree acute del bambino e prevenzione della sensibilizzazione allergica verso alimenti introdotti nella fase
EP1206523B1 (en)	1999-08-05	2009-03-11	Société des Produits Nestlé S.A.	Bifidobacteria preventing diarrhea caused by pathogenic bacteria
TR200200300T2 (tr)	1999-08-05	2003-03-21	Societe Des Produits Nestle S.A.	İshali önlemeye elverişli bifidobakteriler.
EP1384483A1 (en) *	2002-07-23	2004-01-28	Nestec S.A.	Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
WO2004069156A2 (en) *	2003-01-30	2004-08-19	The Regents Of The University Of California	Inactivated probiotic bacteria and methods of use thereof
JP5411405B2 (ja)	2004-03-16	2014-02-12	コンビ株式会社	家畜・家禽用下痢抑制剤
EP1743647B1 (en) *	2004-03-31	2016-12-28	Meiji Co., Ltd.	Antibacterial composition
US7648270B2 (en) *	2004-04-02	2010-01-19	Avago Technologies General Ip (Singapore) Pte. Ltd.	Temperature measurement of an integrated circuit
US7603432B2 (en) *	2005-06-06	2009-10-13	Aa, Llc	Locality based alert method and apparatus
ATE544457T1 (de) *	2007-02-28	2012-02-15	Mead Johnson Nutrition Co	Verfahren zur behandlung bzw. prävention systemischer entzündungen
WO2008153377A1 (en) *	2007-06-15	2008-12-18	N.V. Nutricia	Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
CA2707656C (en) *	2007-12-06	2018-05-22	Arla Foods Amba	Probiotic bacteria and regulation of fat storage
EP2251020A1 (en)	2009-05-11	2010-11-17	Nestec S.A.	Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
ES2559008T3 (es) *	2009-05-11	2016-02-10	Nestec S.A.	Bifidobacterium longum NCC2705 no replicante y trastornos inmunitarios
EP2251022A1 (en) *	2009-05-11	2010-11-17	Nestec S.A.	Non-replicating micro-organisms and their immune boosting effect
EP2308498A1 (en)	2009-09-30	2011-04-13	Nestec S.A.	Administration of Bifidobacterium breve during infancy to prevent inflammation later in life
EP2449890A1 (en) *	2010-11-05	2012-05-09	Nestec S.A.	Powdered cereal compositions comprising non-replicating probiotic microorganisms
ES2565407T3 (es) *	2010-11-05	2016-04-04	Nestec S.A.	Procedimiento para la preparación de un producto alimenticio para animales de compañía, el cual contiene microorganismos probióticos
EP2449889A1 (en) *	2010-11-05	2012-05-09	Nestec S.A.	Rice pudding preparations containing probiotic micro-organisms
EP2449891A1 (en) *	2010-11-05	2012-05-09	Nestec S.A.	Drinking yoghurt preparations containing non-replicating probiotic micro-organisms
EP2455093A1 (en) *	2010-11-11	2012-05-23	Nestec S.A.	Non-replicating probiotic bacteria and prevention or treatment of infections in children

2010
- 2010-11-11 EP EP10190847A patent/EP2455094A1/en not_active Withdrawn
2011
- 2011-11-09 CA CA2817407A patent/CA2817407A1/en not_active Abandoned
- 2011-11-09 US US13/884,524 patent/US9345728B2/en not_active Expired - Fee Related
- 2011-11-09 WO PCT/EP2011/069693 patent/WO2012062781A1/en not_active Ceased
- 2011-11-09 PL PL11784625T patent/PL2637677T3/pl unknown
- 2011-11-09 BR BR112013011759A patent/BR112013011759A2/pt not_active IP Right Cessation
- 2011-11-09 ES ES11784625.3T patent/ES2542956T3/es active Active
- 2011-11-09 PH PH1/2013/500918A patent/PH12013500918A1/en unknown
- 2011-11-09 SG SG2013034699A patent/SG190170A1/en unknown
- 2011-11-09 EP EP11784625.3A patent/EP2637677B1/en not_active Revoked
- 2011-11-09 MX MX2013005370A patent/MX336125B/es unknown
- 2011-11-09 RU RU2013126602/15A patent/RU2568830C2/ru not_active IP Right Cessation
- 2011-11-09 AU AU2011328137A patent/AU2011328137A1/en not_active Abandoned
- 2011-11-09 CN CN2011800642455A patent/CN103282040A/zh active Pending
- 2011-11-09 PT PT117846253T patent/PT2637677E/pt unknown
2013
- 2013-05-07 IL IL226210A patent/IL226210A0/en unknown
- 2013-05-10 CL CL2013001313A patent/CL2013001313A1/es unknown
- 2013-06-10 ZA ZA2013/04245A patent/ZA201304245B/en unknown

Also Published As

Publication number	Publication date
EP2637677A1 (en)	2013-09-18
CN103282040A (zh)	2013-09-04
BR112013011759A2 (pt)	2016-09-13
MX2013005370A (es)	2013-06-28
CA2817407A1 (en)	2012-05-18
PL2637677T3 (pl)	2015-11-30
AU2011328137A1 (en)	2013-05-30
US9345728B2 (en)	2016-05-24
EP2455094A1 (en)	2012-05-23
SG190170A1 (en)	2013-06-28
RU2013126602A (ru)	2014-12-20
ZA201304245B (en)	2016-02-24
US20130224254A1 (en)	2013-08-29
ES2542956T3 (es)	2015-08-13
PH12013500918A1 (en)	2017-08-23
RU2568830C2 (ru)	2015-11-20
EP2637677B1 (en)	2015-06-17
IL226210A0 (en)	2013-07-31
WO2012062781A1 (en)	2012-05-18
MX336125B (es)	2016-01-07
PT2637677E (pt)	2015-09-11

Publication	Publication Date	Title
BR112013011881A2 (pt)	2016-11-01	micro-organismos probióticos não replicantes que protegem contra infecções do trato respiratório superior
CL2013001134A1 (es)	2014-02-28	Composicion de yogurt congelado que comprende microorganismos probioticos no replicantes .
BR112013016535A2 (pt)	2016-09-20	extratos vegetais para o tratamento e prevenção de infecções
PT2613774T (pt)	2018-05-22	Combinação de fenoxibenzamina e polimixina e para tratar infeções microbianas
CL2012000487A1 (es)	2012-08-31	Composicion que comprende bifidobacterium longum baa-999 para tratar y/o prevenir trastornos gi funcionales.
EP2558999A4 (en)	2014-04-16	SOCIAL NETWORK HOMEPAGE
CO6801729A2 (es)	2013-11-29	Composiciones y métodos para modular el fxr
BR112013012598A2 (pt)	2016-08-09	composição de oligossacarídeos para tratar infecções agudas do trato respiratório
FI20100022L (fi)	2011-07-26	Aine ja koostumus öljykenttäsovelluksiin
PL2477638T3 (pl)	2018-12-31	Stabilizacja probiotyku
HRP20160737T1 (hr)	2016-07-15	Anti-her3-protutijela i njihove uporabe
ES2898695T8 (es)	2022-03-16	Derivados de benzoxaborol para el tratamiento de infecciones bacterianas
EP3542638C0 (en)	2024-12-25	Nutritional composition
HRP20160922T1 (hr)	2016-10-07	Oligopeptidni spojevi i njihove uporabe
CO6801724A2 (es)	2013-11-29	Composiciones y métodos para el tratamiento de la mielofibrosis
BR112012027165A2 (pt)	2016-07-19	composição e artigo
IL225607A0 (en)	2013-06-27	Heteroaryls and uses thereof
CL2014002348A1 (es)	2015-01-23	Compuestos derivados de fenicol; composicion farmaceutica que los comprende; y su uso para controlar o tratar infecciones bacterianas en ganado.
CL2013001313A1 (es)	2014-03-07	Composicion que comprende microorganismos probióticos no replicantes para prevenir o tratar infecciones gastrointestinales
CL2013001315A1 (es)	2013-08-02	Composicion que comprende micro-organismo probioticos no replicantes extruidos.
PL2612904T3 (pl)	2017-07-31	Kompozycje przeciwpróchnicze i probiotyki/prebiotyki
CL2013001314A1 (es)	2014-02-14	Composicion de yogur de consistencia espesa que comprende microorganismos probióticos no replicantes.
BR112013016223A2 (pt)	2016-08-09	películas e composições compreendendo as mesmas
BRPI0912687A2 (pt)	2016-01-26	uso de bactéria probiótica para o tratamento de hiperhomocisteinaemia
EP2433996A4 (en)	2012-08-01	LIQUID COMPOSITION AND ENDOSCOPE